Speaker illustration

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

Member of:

European Society of Cardiology
Heart Failure Association of the ESC

Lars Lund is Professor of Cardiology at Karolinska Institutet and Karolinska University Hospital in Stockholm. His research focuses on heart failure: implementation of existing therapy in HFrEF and development of novel therapy in HFpEF.

Remote care in heart failure - challenges and solutions

Event: Heart Failure 2025

Topic: Multidisciplinary Interventions

Session type: Moderated ePosters

Thumbnail

Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?

Event: Heart Failure 2025

Topic: Aldosterone Antagonists

Session type: Satellite Symposium

Thumbnail

Research methodology

Event: Heart Failure 2024

Topic: Research Methodology

Session type: Moderated ePosters

Thumbnail

Late breaking science: registries

Event: Heart Failure 2024

Topic: Heart Failure Association (HFA)

Session type: Late-Breaking Science

Thumbnail

New tools to detect and treat acute heart failure

Event: Heart Failure 2024

Topic: Acute Heart Failure

Session type: Rapid Fire Abstracts

Thumbnail

Registry-based research in heart failure: when is it useful?

Event: Heart Failure 2023

Topic: Big Data Analysis

Session type: Symposium

Thumbnail

HF clinical trials of 2022

Event: Heart Failure 2023

Topic: Heart Failure Association (HFA)

Session type: Case-Based Session

Thumbnail

Chronic heart failure - HFpEF - HFrEF - HFmREF

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session type: Moderated ePosters

Thumbnail

HFpEF and HFmrEF: what’s new in treatment?

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session type: Abstract Sessions

Thumbnail

Registries and Trial updates II

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Thumbnail